Covestor’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-13
Closed -$3K – 2515
2026
Q2
$3K Hold
13
– – ﹤0.01% 1936
2026
Q1
$3K Hold
13
– – ﹤0.01% 1907
2025
Q4
$3K Hold
13
– – ﹤0.01% 1872
2025
Q3
$2K Hold
13
– – ﹤0.01% 1940
2025
Q2
$2K Hold
13
– – ﹤0.01% 1846
2025
Q1
$2K Hold
13
– – ﹤0.01% 1839
2024
Q4
$2K Hold
13
– – ﹤0.01% 1869
2024
Q3
$2K Hold
13
– – ﹤0.01% 1813
2024
Q2
$2K Hold
13
– – ﹤0.01% 1847
2024
Q1
$2K Hold
13
– – ﹤0.01% 1846
2023
Q4
$2K Hold
13
– – ﹤0.01% 1844
2023
Q3
$2K Hold
13
– – ﹤0.01% 1809
2023
Q2
$2K Hold
13
– – ﹤0.01% 1818
2023
Q1
$2K Buy
+13
New +$2.04K ﹤0.01% 1750

Other funds holding FBT

Covestor's FBT Position: Q3 2026 in Review

Covestor sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2026, closing a stake of 13 shares — an estimated $3K sold.

Covestor first reported a position in FBT in Q1 2023 and held it in 14 quarters. The position peaked at $3K in Q2 2026. 311 funds tracked by Wall St. Rank hold FBT as of Q3 2026.

  • Covestor reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2026 after selling out during the quarter.
  • Covestor sold 13 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2026, an estimated $3K.
  • Covestor first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2023 and held it in 14 quarters.
  • Covestor's First Trust NYSE Arca Biotechnology Index Fund position peaked at $3K in Q2 2026.
  • 311 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.